Department of Intensive Care Unit, No. 3 People's Hospital of Xuzhou, Jiangsu Province, 221000, China.
Biomark Med. 2024;18(15-16):659-664. doi: 10.1080/17520363.2024.2377534. Epub 2024 Aug 13.
We hypothesized plasma sEH activity correlates with mortality in acute respiratory distress syndrome (ARDS) patients. Adult patients diagnosed with ARDS enrolled between 2017 and 2019 were included in this study. A total of 337 adult patients met our inclusion criteria. Among them, 107 patients died within 28 days. The plasma sEH activity was higher in nonsurvivors relative to survivors. And a receiver operating characteristic curve with the area under the curve of 0.81 (95% confidence interval: 0.74-0.89) for the prediction of 28-day mortality was obtained. Its sensitivity and specificity were 72.5% and 74.6%, respectively. Elevated plasma sEH activity is associated with higher 28-day mortality in adult patients with ARDS.
我们假设血浆 sEH 活性与急性呼吸窘迫综合征(ARDS)患者的死亡率相关。本研究纳入了 2017 年至 2019 年间被诊断为 ARDS 的成年患者。共有 337 名成年患者符合纳入标准。其中,107 名患者在 28 天内死亡。与幸存者相比,非幸存者的血浆 sEH 活性更高。获得预测 28 天死亡率的曲线下面积为 0.81(95%置信区间:0.74-0.89)的受试者工作特征曲线。其敏感性和特异性分别为 72.5%和 74.6%。在成年 ARDS 患者中,血浆 sEH 活性升高与 28 天死亡率升高相关。